<p>NeueHealth, Inc.（紐約證券交易所代碼：NEUE - 獲取免費報告）董事 Anthony Jr. Florence 於 10 月 2 日星期四出售了 4,195 股該股票。股票的平均售價為 6.75 美元，總交易額為 28,316.25 美元。交易後，該董事在公司持有 488,702 股，估值約為 3,298,738.50 美元。此次交易代表其持股減少了 0.85%。該出售在向證券交易委員會的法律文件中披露，相關信息可通過此鏈接獲取。</p>
<h2>NeueHealth 股票表現</h2>
<p>在週一的午盤交易中，NeueHealth 股票保持在 6.75 美元不變。NeueHealth, Inc.的十二個月最低價為 3.79 美元，最高價為 7.66 美元。該公司的 50 日簡單移動平均線為 6.72 美元，200 日簡單移動平均線也為 6.72 美元。該公司的市值為 6094 萬美元，市盈率為-0.42，貝塔值為 0.59。</p>
<p>NeueHealth（紐約證券交易所代碼：NEUE - 獲取免費報告）最近在 8 月 7 日星期四發佈了季度財報。該公司報告本季度每股收益（EPS）為-1.68 美元，超出分析師一致預期的-4.77 美元，差額為 3.09 美元。該季度的收入為 2.0908 億美元，而分析師預期為 2.495 億美元。分析師平均預測 NeueHealth, Inc.在本財年將發佈每股收益-9.13 美元。</p>
<h2>機構資金流入和流出</h2>
<p>一家對沖基金最近在 NeueHealth 股票中購買了新股份。根據該公司在最近向證券交易委員會提交的 13F 表格，PenderFund Capital Management Ltd.在第一季度購買了 NeueHealth, Inc.（紐約證券交易所代碼：NEUE - 免費報告）的新股份。該基金購買了 29,115 股公司股票，估值約為 197,000 美元。PenderFund Capital Management Ltd.在最近的報告期末持有 NeueHealth 的 0.33%。對沖基金和其他機構投資者持有該公司 63.88% 的股票。</p>
<h2>分析師評級上調和下調</h2>
<p>另外，Weiss Ratings 在 9 月 27 日星期六的報告中重申了對 NeueHealth 股票的 “賣出（e+）” 評級。一位分析師對該股票給予了持有評級，另一位則給予了賣出評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “減持”，共識目標價為 7.00 美元。</p>
<p><strong>獲取我們對 NEUE 的最新分析</strong></p>
<h2>關於 NeueHealth</h2>
<p>（獲取免費報告）</p>
<p>NeueHealth, Inc.是一家醫療保健公司，為美國的健康消費者、提供者和支付方提供各種醫療服務。它通過兩個部門運營：NeueCare 和 NeueSolutions。NeueCare 部門通過自有和附屬診所向 ACA 市場、醫療保險和醫療補助提供醫療服務。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票比 NeueHealth 更好</li>
<li>什麼是低市盈率，它對投資者意味着什麼？</li>
<li>3 只卓越股票以建立長期財富</li>
<li>零售股票投資，詳解</li>
<li>Broadcom 和 CoreWeave 的內部銷售激增：前景警示？</li>
<li>標普 500 股票對投資者市場的啓示是什麼？</li>
<li>Marvell 內部人士購買股票——投資者應該跟隨嗎？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5FVUU?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5FVUU"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 NeueHealth 嗎？</h2>
<p>在考慮 NeueHealth 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 NeueHealth 並不在名單上。</p>
<p>雖然 NeueHealth 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

NEUE

<p>NeueHealth, Inc.（紐約證券交易所代碼：NEUE）的董事 Anthony Jr. Florence 於 10 月 2 日以每股 6.75 美元的價格出售了 4,195 股，總計 28,316.25 美元。出售後，他持有 488,702 股，價值約 330 萬美元，反映出其持股減少了 0.85%。該股票在交易中保持平穩，價格為 6.75 美元。分析師對該股票的共識評級為 “減持”，目標價為 7.00 美元。機構投資者持有 NeueHealth 63.88% 的股份，該公司報告的季度每股收益為（1.68 美元），超出預期</p>

<p>NeueHealth, Inc. (NYSE:NEUE - Get Free Report) Director Anthony Jr. Florence sold 4,195 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total transaction of $28,316.25. Following the transaction, the director owned 488,702 shares in the company, valued at approximately $3,298,738.50. This trade represents a 0.85% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this link.</p>
<div class="lb-trans"><p>NeueHealth, Inc.（紐約證券交易所代碼：NEUE - 獲取免費報告）董事 Anthony Jr. Florence 於 10 月 2 日星期四出售了 4,195 股該股票。股票的平均售價為 6.75 美元，總交易額為 28,316.25 美元。交易後，該董事在公司持有 488,702 股，估值約為 3,298,738.50 美元。此次交易代表其持股減少了 0.85%。該出售在向證券交易委員會的法律文件中披露，相關信息可通過此鏈接獲取。</p>
</div><h2>NeueHealth Stock Performance</h2>
<div class="lb-trans"><h2>NeueHealth 股票表現</h2>
</div><p>NeueHealth stock remained flat at $6.75 during mid-day trading on Monday. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66. The company has a fifty day simple moving average of $6.72 and a two-hundred day simple moving average of $6.72. The firm has a market capitalization of $60.94 million, a PE ratio of -0.42 and a beta of 0.59.</p>
<div class="lb-trans"><p>在週一的午盤交易中，NeueHealth 股票保持在 6.75 美元不變。NeueHealth, Inc.的十二個月最低價為 3.79 美元，最高價為 7.66 美元。該公司的 50 日簡單移動平均線為 6.72 美元，200 日簡單移動平均線也為 6.72 美元。該公司的市值為 6094 萬美元，市盈率為-0.42，貝塔值為 0.59。</p>
</div><p>NeueHealth (NYSE:NEUE - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, beating analysts' consensus estimates of ($4.77) by $3.09. The company had revenue of $209.08 million for the quarter, compared to analyst estimates of $249.50 million. On average, analysts forecast that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>NeueHealth（紐約證券交易所代碼：NEUE - 獲取免費報告）最近在 8 月 7 日星期四發佈了季度財報。該公司報告本季度每股收益（EPS）為-1.68 美元，超出分析師一致預期的-4.77 美元，差額為 3.09 美元。該季度的收入為 2.0908 億美元，而分析師預期為 2.495 億美元。分析師平均預測 NeueHealth, Inc.在本財年將發佈每股收益-9.13 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. purchased a new stake in NeueHealth, Inc. (NYSE:NEUE - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 29,115 shares of the company's stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned 0.33% of NeueHealth at the end of the most recent reporting period. Hedge funds and other institutional investors own 63.88% of the company's stock.</p>
<div class="lb-trans"><p>一家對沖基金最近在 NeueHealth 股票中購買了新股份。根據該公司在最近向證券交易委員會提交的 13F 表格，PenderFund Capital Management Ltd.在第一季度購買了 NeueHealth, Inc.（紐約證券交易所代碼：NEUE - 免費報告）的新股份。該基金購買了 29,115 股公司股票，估值約為 197,000 美元。PenderFund Capital Management Ltd.在最近的報告期末持有 NeueHealth 的 0.33%。對沖基金和其他機構投資者持有該公司 63.88% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調和下調</h2>
</div><p>Separately, Weiss Ratings reiterated a &#34;sell (e+)&#34; rating on shares of NeueHealth in a report on Saturday, September 27th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of &#34;Reduce&#34; and a consensus price target of $7.00.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 9 月 27 日星期六的報告中重申了對 NeueHealth 股票的 “賣出（e+）” 評級。一位分析師對該股票給予了持有評級，另一位則給予了賣出評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “減持”，共識目標價為 7.00 美元。</p>
</div><p><strong>Get Our Latest Analysis on NEUE</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 NEUE 的最新分析</strong></p>
</div><h2>About NeueHealth</h2>
<div class="lb-trans"><h2>關於 NeueHealth</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.</p>
<div class="lb-trans"><p>NeueHealth, Inc.是一家醫療保健公司，為美國的健康消費者、提供者和支付方提供各種醫療服務。它通過兩個部門運營：NeueCare 和 NeueSolutions。NeueCare 部門通過自有和附屬診所向 ACA 市場、醫療保險和醫療補助提供醫療服務。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than NeueHealth</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>3 Exceptional Stocks to Build Long-Term Wealth</li>
<li>Retail Stocks Investing, Explained</li>
<li>Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?</li>
<li>What Do S&amp;P 500 Stocks Tell Investors About the Market?</li>
<li>Marvell Insiders Buy Shares—Should Investors Follow Suit?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票比 NeueHealth 更好</li>
<li>什麼是低市盈率，它對投資者意味着什麼？</li>
<li>3 只卓越股票以建立長期財富</li>
<li>零售股票投資，詳解</li>
<li>Broadcom 和 CoreWeave 的內部銷售激增：前景警示？</li>
<li>標普 500 股票對投資者市場的啓示是什麼？</li>
<li>Marvell 內部人士購買股票——投資者應該跟隨嗎？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5FVUU" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=NEUE"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in NeueHealth Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 NeueHealth 嗎？</h2>
</div><p>Before you consider NeueHealth, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 NeueHealth 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 NeueHealth 並不在名單上。</p>
</div><p>While NeueHealth currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 NeueHealth 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Anthony Jr. Florence 出售了 4,195 股 NeueHealth (NYSE:NEUE) 的股票